All patients (n = 244) | With chronic infection (n = 19) | Without chronic infection (n = 225) | P value | |
---|---|---|---|---|
SF-36 | ||||
Physical functioning | 90 (75–95) | 85 (69–90) | 90 (78–95) | 0.029 |
Role-physical | 88 (63–100) | 75 (56–88) | 88 (63–100) | 0.057 |
Bodily pain | 74 (52–100) | 74 (41–100) | 74 (52–100) | 0.269 |
General health | 52 (40–62) | 47 (40–52) | 52 (40–65) | 0.292 |
Vitality | 63 (44–75) | 56 (50–75) | 63 (44–75) | 0.654 |
Social functioning | 88 (63–100) | 75 (38–100) | 88 (63–100) | 0.135 |
Role-emotional | 92 (58–100) | 92 (58–100) | 92 (58–100) | 0.926 |
Mental health | 75 (60–85) | 70 (55–80) | 75 (60–85) | 0.461 |
PCS | 48 (40–54) | 40 (36–48) | 48 (40–54) | 0.071 |
MCS | 50 (44–56) | 49 (43–55) | 51 (44–46) | 0.702 |
RCS | 51 (39–56) | 50 (34–55) | 51 (40–57) | 0.451 |
SGRQ | ||||
Symptom | 30 (16–48) | 48 (30–52) | 30 (14–46) | 0.008 |
Activity | 24 (6–46) | 35 (19–48) | 23 (6–46) | 0.141 |
Impact | 12 (4–31) | 27 (17–42) | 11 (3–30) | 0.006 |
Total | 20 (8–36) | 30 (23–49) | 18 (8–36) | 0.012 |